These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3431891)

  • 21. [Mechanisms of development of diabetic macroangiopathy].
    Saltykov BB
    Arkh Patol; 2001; 63(2):21-6. PubMed ID: 11392087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
    Peczyńska J; Urban M; Głowińska B; Urban B
    Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunomorphological characteristics of microangiopathy in non-insulin-dependent diabetes mellitus].
    Saltykov BB; Velikov VK; Shubina OI
    Sov Med; 1986; (4):20-4. PubMed ID: 2940702
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dynamic morphologic follow-up of diabetic microangiopathy].
    Saltykov BB; Velikov VK
    Arkh Patol; 2000; 62(6):42-6. PubMed ID: 11198122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diabetic microangiopathy: does a genetic susceptibility HLA-correlated exist?].
    Scaldaferri E; Devidè A
    Minerva Endocrinol; 1985; 10(2):115-24. PubMed ID: 3906376
    [No Abstract]   [Full Text] [Related]  

  • 27. Accessibility of human apolipoprotein B-100 epitopes in insulin-dependent diabetes: relation with the surface lipid environment of atherogenic particles.
    Ziegler O; Méjean L; Igau B; Fruchart JC; Drouin P; Fiévet C
    Diabetes Metab; 1996 Jun; 22(3):179-84. PubMed ID: 8697305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
    Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
    Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Assessment of growth factor levels in adolescents with type 1 diabetes mellitus and the beginning of diabetic microangiopathy].
    Peczyńska J; Urban M; Urban B; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):41-8. PubMed ID: 15355738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes.
    Senaldi G; Millward BA; Hussain MJ; Pyke DA; Leslie RD; Vergani D
    J Clin Pathol; 1988 Oct; 41(10):1114-6. PubMed ID: 3192734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.
    Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M
    Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
    Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
    Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between the level of plasma D-dimer and diabetic microangiopathy].
    Long ZF; Qu GY; Xu M
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):434-6. PubMed ID: 12536492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of diabetic microangiopathy and diabetic control. A study in non-insulin-dependent diabetics.
    Maneschi F; Cassar J; Lowy C; Kohner EM
    Diabete Metab; 1981 Sep; 7(3):181-7. PubMed ID: 7033009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Importance of immunological shifts in the development of diabetes mellitus and cardiovascular pathology in children and adolescents].
    Balabolkin MI; Sarana VA; Stuliĭ LA; Belozorova NI; Terebkova IV
    Vestn Akad Med Nauk SSSR; 1983; (2):33-9. PubMed ID: 6340363
    [No Abstract]   [Full Text] [Related]  

  • 37. The genetics of diabetic complications.
    Barnett AH; Pyke DA
    Clin Endocrinol Metab; 1986 Nov; 15(4):715-26. PubMed ID: 3536196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diabetic microangiopathy (based on the morphological study data from skin biopsies)].
    Saltykov BB
    Arkh Patol; 1981; 43(3):42-7. PubMed ID: 7236031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.